12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Other News

Pfizer biosimilars, generics news

Pfizer said it plans to integrate its commercial operations for developed and emerging markets and internally separate the operations into three business segments starting in January. The pharma currently has two operating models in developed markets - an innovative segment focused on patent protected products and a...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >